Global Antibodies Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antibodies Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Antibodies by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Antibodies by Country/Region, 2017, 2022 & 2028

2.2 Antibodies Segment by Type

2.2.1 Monoclonal antibodies

2.2.2 Polyclonal antibodies

2.2.3 Antibody drug conjugates

2.3 Antibodies Sales by Type

2.3.1 Global Antibodies Sales Market Share by Type (2017-2022)

2.3.2 Global Antibodies Revenue and Market Share by Type (2017-2022)

2.3.3 Global Antibodies Sale Price by Type (2017-2022)

2.4 Antibodies Segment by Application

2.4.1 Hospitals

2.4.2 Long-term care facilities

2.4.3 Research institutes

2.5 Antibodies Sales by Application

2.5.1 Global Antibodies Sale Market Share by Application (2017-2022)

2.5.2 Global Antibodies Revenue and Market Share by Application (2017-2022)

2.5.3 Global Antibodies Sale Price by Application (2017-2022)

3 Global Antibodies by Company

3.1 Global Antibodies Breakdown Data by Company

3.1.1 Global Antibodies Annual Sales by Company (2020-2022)

3.1.2 Global Antibodies Sales Market Share by Company (2020-2022)

3.2 Global Antibodies Annual Revenue by Company (2020-2022)

3.2.1 Global Antibodies Revenue by Company (2020-2022)

3.2.2 Global Antibodies Revenue Market Share by Company (2020-2022)

3.3 Global Antibodies Sale Price by Company

3.4 Key Manufacturers Antibodies Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Antibodies Product Location Distribution

3.4.2 Players Antibodies Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Antibodies by Geographic Region

4.1 World Historic Antibodies Market Size by Geographic Region (2017-2022)

4.1.1 Global Antibodies Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Antibodies Annual Revenue by Geographic Region

4.2 World Historic Antibodies Market Size by Country/Region (2017-2022)

4.2.1 Global Antibodies Annual Sales by Country/Region (2017-2022)

4.2.2 Global Antibodies Annual Revenue by Country/Region

4.3 Americas Antibodies Sales Growth

4.4 APAC Antibodies Sales Growth

4.5 Europe Antibodies Sales Growth

4.6 Middle East & Africa Antibodies Sales Growth

5 Americas

5.1 Americas Antibodies Sales by Country

5.1.1 Americas Antibodies Sales by Country (2017-2022)

5.1.2 Americas Antibodies Revenue by Country (2017-2022)

5.2 Americas Antibodies Sales by Type

5.3 Americas Antibodies Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antibodies Sales by Region

6.1.1 APAC Antibodies Sales by Region (2017-2022)

6.1.2 APAC Antibodies Revenue by Region (2017-2022)

6.2 APAC Antibodies Sales by Type

6.3 APAC Antibodies Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Antibodies by Country

7.1.1 Europe Antibodies Sales by Country (2017-2022)

7.1.2 Europe Antibodies Revenue by Country (2017-2022)

7.2 Europe Antibodies Sales by Type

7.3 Europe Antibodies Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antibodies by Country

8.1.1 Middle East & Africa Antibodies Sales by Country (2017-2022)

8.1.2 Middle East & Africa Antibodies Revenue by Country (2017-2022)

8.2 Middle East & Africa Antibodies Sales by Type

8.3 Middle East & Africa Antibodies Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Antibodies

10.3 Manufacturing Process Analysis of Antibodies

10.4 Industry Chain Structure of Antibodies

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Antibodies Distributors

11.3 Antibodies Customer

12 World Forecast Review for Antibodies by Geographic Region

12.1 Global Antibodies Market Size Forecast by Region

12.1.1 Global Antibodies Forecast by Region (2023-2028)

12.1.2 Global Antibodies Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Antibodies Forecast by Type

12.7 Global Antibodies Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Antibodies Product Offered

13.1.3 Novartis Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 F. Hoffmann-La Roche

13.2.1 F. Hoffmann-La Roche Company Information

13.2.2 F. Hoffmann-La Roche Antibodies Product Offered

13.2.3 F. Hoffmann-La Roche Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 F. Hoffmann-La Roche Main Business Overview

13.2.5 F. Hoffmann-La Roche Latest Developments

13.3 Johnson & Johnson Services

13.3.1 Johnson & Johnson Services Company Information

13.3.2 Johnson & Johnson Services Antibodies Product Offered

13.3.3 Johnson & Johnson Services Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Johnson & Johnson Services Main Business Overview

13.3.5 Johnson & Johnson Services Latest Developments

13.4 Amgen

13.4.1 Amgen Company Information

13.4.2 Amgen Antibodies Product Offered

13.4.3 Amgen Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amgen Main Business Overview

13.4.5 Amgen Latest Developments

13.5 Bristol-Myers Squibb

13.5.1 Bristol-Myers Squibb Company Information

13.5.2 Bristol-Myers Squibb Antibodies Product Offered

13.5.3 Bristol-Myers Squibb Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bristol-Myers Squibb Main Business Overview

13.5.5 Bristol-Myers Squibb Latest Developments

13.6 AbbVie

13.6.1 AbbVie Company Information

13.6.2 AbbVie Antibodies Product Offered

13.6.3 AbbVie Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AbbVie Main Business Overview

13.6.5 AbbVie Latest Developments

13.7 Eli Lilly

13.7.1 Eli Lilly Company Information

13.7.2 Eli Lilly Antibodies Product Offered

13.7.3 Eli Lilly Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Eli Lilly Main Business Overview

13.7.5 Eli Lilly Latest Developments

14 Research Findings and Conclusion

Table 1. Antibodies Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Antibodies Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Monoclonal antibodies

Table 4. Major Players of Polyclonal antibodies

Table 5. Major Players of Antibody drug conjugates

Table 6. Global Antibodies Sales by Type (2017-2022) & (K Units)

Table 7. Global Antibodies Sales Market Share by Type (2017-2022)

Table 8. Global Antibodies Revenue by Type (2017-2022) & ($ million)

Table 9. Global Antibodies Revenue Market Share by Type (2017-2022)

Table 10. Global Antibodies Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Antibodies Sales by Application (2017-2022) & (K Units)

Table 12. Global Antibodies Sales Market Share by Application (2017-2022)

Table 13. Global Antibodies Revenue by Application (2017-2022)

Table 14. Global Antibodies Revenue Market Share by Application (2017-2022)

Table 15. Global Antibodies Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Antibodies Sales by Company (2020-2022) & (K Units)

Table 17. Global Antibodies Sales Market Share by Company (2020-2022)

Table 18. Global Antibodies Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Antibodies Revenue Market Share by Company (2020-2022)

Table 20. Global Antibodies Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Antibodies Producing Area Distribution and Sales Area

Table 22. Players Antibodies Products Offered

Table 23. Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Antibodies Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Antibodies Sales Market Share Geographic Region (2017-2022)

Table 28. Global Antibodies Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Antibodies Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Antibodies Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Antibodies Sales Market Share by Country/Region (2017-2022)

Table 32. Global Antibodies Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Antibodies Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Antibodies Sales by Country (2017-2022) & (K Units)

Table 35. Americas Antibodies Sales Market Share by Country (2017-2022)

Table 36. Americas Antibodies Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Antibodies Revenue Market Share by Country (2017-2022)

Table 38. Americas Antibodies Sales by Type (2017-2022) & (K Units)

Table 39. Americas Antibodies Sales Market Share by Type (2017-2022)

Table 40. Americas Antibodies Sales by Application (2017-2022) & (K Units)

Table 41. Americas Antibodies Sales Market Share by Application (2017-2022)

Table 42. APAC Antibodies Sales by Region (2017-2022) & (K Units)

Table 43. APAC Antibodies Sales Market Share by Region (2017-2022)

Table 44. APAC Antibodies Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Antibodies Revenue Market Share by Region (2017-2022)

Table 46. APAC Antibodies Sales by Type (2017-2022) & (K Units)

Table 47. APAC Antibodies Sales Market Share by Type (2017-2022)

Table 48. APAC Antibodies Sales by Application (2017-2022) & (K Units)

Table 49. APAC Antibodies Sales Market Share by Application (2017-2022)

Table 50. Europe Antibodies Sales by Country (2017-2022) & (K Units)

Table 51. Europe Antibodies Sales Market Share by Country (2017-2022)

Table 52. Europe Antibodies Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Antibodies Revenue Market Share by Country (2017-2022)

Table 54. Europe Antibodies Sales by Type (2017-2022) & (K Units)

Table 55. Europe Antibodies Sales Market Share by Type (2017-2022)

Table 56. Europe Antibodies Sales by Application (2017-2022) & (K Units)

Table 57. Europe Antibodies Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Antibodies Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Antibodies Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Antibodies Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Antibodies Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Antibodies Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Antibodies Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Antibodies Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Antibodies Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Antibodies

Table 67. Key Market Challenges & Risks of Antibodies

Table 68. Key Industry Trends of Antibodies

Table 69. Antibodies Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Antibodies Distributors List

Table 72. Antibodies Customer List

Table 73. Global Antibodies Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Antibodies Sales Market Forecast by Region

Table 75. Global Antibodies Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Antibodies Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Antibodies Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Antibodies Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Antibodies Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Antibodies Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Antibodies Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Antibodies Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Antibodies Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Antibodies Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Antibodies Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Antibodies Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Antibodies Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Antibodies Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Antibodies Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Antibodies Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Antibodies Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Antibodies Revenue Market Share Forecast by Application (2023-2028)

Table 93. Novartis Basic Information, Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 94. Novartis Antibodies Product Offered

Table 95. Novartis Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Novartis Main Business

Table 97. Novartis Latest Developments

Table 98. F. Hoffmann-La Roche Basic Information, Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 99. F. Hoffmann-La Roche Antibodies Product Offered

Table 100. F. Hoffmann-La Roche Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. F. Hoffmann-La Roche Main Business

Table 102. F. Hoffmann-La Roche Latest Developments

Table 103. Johnson & Johnson Services Basic Information, Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 104. Johnson & Johnson Services Antibodies Product Offered

Table 105. Johnson & Johnson Services Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Johnson & Johnson Services Main Business

Table 107. Johnson & Johnson Services Latest Developments

Table 108. Amgen Basic Information, Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 109. Amgen Antibodies Product Offered

Table 110. Amgen Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Amgen Main Business

Table 112. Amgen Latest Developments

Table 113. Bristol-Myers Squibb Basic Information, Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 114. Bristol-Myers Squibb Antibodies Product Offered

Table 115. Bristol-Myers Squibb Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Bristol-Myers Squibb Main Business

Table 117. Bristol-Myers Squibb Latest Developments

Table 118. AbbVie Basic Information, Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 119. AbbVie Antibodies Product Offered

Table 120. AbbVie Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. AbbVie Main Business

Table 122. AbbVie Latest Developments

Table 123. Eli Lilly Basic Information, Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 124. Eli Lilly Antibodies Product Offered

Table 125. Eli Lilly Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Eli Lilly Main Business

Table 127. Eli Lilly Latest Developments

List of Figures

Figure 1. Picture of Antibodies

Figure 2. Antibodies Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Antibodies Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Antibodies Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Antibodies Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Monoclonal antibodies

Figure 10. Product Picture of Polyclonal antibodies

Figure 11. Product Picture of Antibody drug conjugates

Figure 12. Global Antibodies Sales Market Share by Type in 2021

Figure 13. Global Antibodies Revenue Market Share by Type (2017-2022)

Figure 14. Antibodies Consumed in Hospitals

Figure 15. Global Antibodies Market: Hospitals (2017-2022) & (K Units)

Figure 16. Antibodies Consumed in Long-term care facilities

Figure 17. Global Antibodies Market: Long-term care facilities (2017-2022) & (K Units)

Figure 18. Antibodies Consumed in Research institutes

Figure 19. Global Antibodies Market: Research institutes (2017-2022) & (K Units)

Figure 20. Global Antibodies Sales Market Share by Application (2017-2022)

Figure 21. Global Antibodies Revenue Market Share by Application in 2021

Figure 22. Antibodies Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Antibodies Revenue Market Share by Company in 2021

Figure 24. Global Antibodies Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Antibodies Revenue Market Share by Geographic Region in 2021

Figure 26. Global Antibodies Sales Market Share by Region (2017-2022)

Figure 27. Global Antibodies Revenue Market Share by Country/Region in 2021

Figure 28. Americas Antibodies Sales 2017-2022 (K Units)

Figure 29. Americas Antibodies Revenue 2017-2022 ($ Millions)

Figure 30. APAC Antibodies Sales 2017-2022 (K Units)

Figure 31. APAC Antibodies Revenue 2017-2022 ($ Millions)

Figure 32. Europe Antibodies Sales 2017-2022 (K Units)

Figure 33. Europe Antibodies Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Antibodies Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Antibodies Revenue 2017-2022 ($ Millions)

Figure 36. Americas Antibodies Sales Market Share by Country in 2021

Figure 37. Americas Antibodies Revenue Market Share by Country in 2021

Figure 38. United States Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Antibodies Sales Market Share by Region in 2021

Figure 43. APAC Antibodies Revenue Market Share by Regions in 2021

Figure 44. China Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Antibodies Sales Market Share by Country in 2021

Figure 51. Europe Antibodies Revenue Market Share by Country in 2021

Figure 52. Germany Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Antibodies Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Antibodies Revenue Market Share by Country in 2021

Figure 59. Egypt Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Antibodies Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Antibodies in 2021

Figure 65. Manufacturing Process Analysis of Antibodies

Figure 66. Industry Chain Structure of Antibodies

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles